Evaluate the effect of autoantibodies by measuring baseline IFNα and cytokines with Simoa® technology
Autoantibodies are known to be involved in systemic lupus erythematosus and other autoimmune diseases. More recently, severe COVID-19 patients were also shown to harbor auto-antibodies against type I interferons. It…
read more